Dear Readers,

We are excited to share with you the first episode of Porter & Co. Open Forum – a new feature to allow readers to ask questions of analysts from all our research advisories. We kick it off with a discussion between Biotech Frontiers editor Erez Kalir and CEO and publisher Kim Iskyan.

In this “ask me anything” format, readers brought questions on a range of topics, including buying a stock that is above its “buy up to” price, managing position sizing in a portfolio, and scientific developments on the effectiveness of antibiotics.

Erez begins the discussion answering Kim’s question about how Erez’s stance on the biotech sector has shifted in recent weeks.